As of October 4, 2012, both the Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration (FDA) have advised that “all health care personnel cease using any product made by New England Compounding Center" due to a nationwide outbreak of fungal meningitis. The Framingham, Massachusetts-based compounding pharmacy voluntarily shut down operations the same day, and an active investigation is underway by both the CDC and FDA.
Read More >>
Voluntary Recall of Methylprednisolone Acetate
Michigan Pain Consultants has been closely following the situation regarding the voluntary recall of methylprednisolone acetate. Be assured we have checked the lot numbers on our inventory of methylprednisolone acetate to confirm our supply is not part of this recall. Our patients will not be effected by this recent development. For more information regarding the recalled methylprednisolone acetate, please follow the link below.